What does "AI visibility" mean for my business?

When someone asks ChatGPT, Claude, or Gemini "what is the best..." or "where can I find...", AI gives specific recommendations. AI visibility is a measure of how often — and how positively — these AI platforms mention your business. It's the new version of being on the first page of Google, except now there are no pages — just one answer.

Which AI platforms do you monitor?

Pendium monitors ChatGPT, Claude, Gemini, Grok, Perplexity, DeepSeek, and Google AI Overviews — seven major AI platforms that consumers use to research local services. We run real queries that your customers actually ask and analyze the responses for mentions of your business, competitors, and industry topics.

How does Pendium improve my visibility?

Three ways. First, we identify the exact queries and topics where you're invisible. Second, we generate AI-optimized content — articles, guides, social posts — designed to help AI agents understand your business and recommend your services to the right people. Third, we continuously monitor to track improvement and find new opportunities. Most clients see measurable improvement within 60 days.

How long until I see results?

You'll get your first visibility report within minutes of signing up. Actual visibility improvement varies, but our clients typically see a 47% average improvement within 60 days. Some see results faster — it depends on your current online presence and how competitive your local market is.

Do I need to be technical to use this?

Not at all. Enter your website URL and Pendium handles everything: scanning AI platforms, analyzing your visibility, generating content, and tracking improvement. The dashboard is designed for business owners, not engineers. If you can check your email, you can use Pendium.

What makes this different from SEO?

Traditional SEO optimizes for Google's search rankings — blue links on a results page. AI visibility is different: AI doesn't show links, it gives direct answers. Even if you rank #1 on Google, ChatGPT might recommend a competitor. Pendium optimizes for the new paradigm — making sure AI platforms know about, trust, and recommend your business.

Pricing

Get a demo

CellType

Visibility20

Vibe79

Businesses/Biotechnology/CellType

AI Visibility & Sentiment

CellType

CellType is a biotechnology company that uses AI foundation models trained on human cell data to simulate drug response in human biology. Their technology helps pharmaceutical companies prioritize drug targets, predict toxicity, and accelerate clinical trials before testing on actual patients.

Active Monitoring

celltype.com

Biotechnology YC25-26

AI Visibility Score

20/100

Low

Sentiment Score

79/100

Score by Reach

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core

adjacent

aspirational

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe CellType today.

CellType is currently a ghost in the AI discovery engines used by high-stakes pharma executives, failing to appear in any queries for the R&D persona despite maintaining a narrow technical foothold on Claude. While industry giants like Schrödinger and Exscientia dominate the 'top player' lists that drive enterprise partnerships, CellType's 0% visibility on ChatGPT and AI Overviews represents a critical failure in the brand's digital authority.

Value Proposition

Simulate drug response in human biology before the first patient, enabling pharma companies to prioritize what to test and accelerate what works while catching toxicity signals that animal models miss.

Overview

Mission

Know how your drug works in humans before the first patient.

Products & Services

Target De-risking - virtual compound screening and target rankingTranslation & Toxicity Prediction - human adverse reaction prediction from preclinical dataClinical Acceleration - virtual patient stratification and responder identificationBiomarker Discovery - assay-ready biomarkers for go/no-go decisionsDiagnostics & Precision Health - multimodal biological data foundation models

Current State

Visibility Landscape

A high-level view of how CellType performs across AI platforms, broken down by strategic reach level — from core brand queries to growth opportunities.

	Claude	Gemini
Reputation Brand recognition & direct queries	30	27
Core Topics Product/service category queries	38	23
Growth Areas Adjacent, aspirational & visionary	35	0

ChatGPT

Claude

Gemini

AI Overviews

Reputation

Brand recognition & direct queries

Core Topics

Product/service category queries

Growth Areas

Adjacent, aspirational & visionary

Competitive Landscape

Schrödinger

24 mentions

Exscientia

19 mentions

BenevolentAI

18 mentions

Insilico Medicine

16 mentions

Emulate

15 mentions

Atomwise

14 mentions

Loading visibility matrix...

Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve CellType's AI visibility.

Key Findings

Strength

Significant resonance within Claude, achieving a 42% mention rate and reaching the #1 position for brand-specific vibe checks.

Strength

Developing a niche presence with Technical Computational Biologists (40% visibility) and Clinical Safety Leads (36%), particularly for simulation-related queries.

Strength

High sentiment scores when mentioned, indicating that while the brand is hard to find, the information available is viewed favorably.

Recommended Actions

Execute a 'De-risking' Content Authority Campaign

CellType is currently missing from every query related to 'de-risking drug targets,' a core industry pain point where competitors are currently defining the standard.

Optimize for ChatGPT and AI Overview indexing via structured technical documentation

With 0% visibility on these platforms, the brand is effectively non-existent for users who rely on these tools for market mapping and vendor discovery.

Develop Executive-Level Whitepapers on AI Toxicity Prediction

The Clinical Safety Lead persona shows interest in CellType, but the brand lacks the authoritative content needed to climb from an average position of 7.8 into a top-3 recommendation.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

De Risking Drug Discovery And Early Screening(3 queries)

“help me find ways to de-risk drug targets using AI before moving to animal studies”

0/4 platforms mentioned

Adjacent

ChatGPT

1.TwoSampleMR

2.MR-Base

3.coloc

4.SMR/HEIDI

5.gnomAD

+81 more

Claude

1.Exscientia

2.Recursion

3.BenevolentAI

4.Insitro

5.AlphaFold

+19 more

Gemini

1.BenevolentAI

2.Causaly

3.Owkin

4.AlphaFold2

5.DeepMind

+14 more

AI Overviews

1.DeepTox

2.Owkin

3.CellProfiler

4.DrugBank

5.SIDER

+1 more

“how can i use foundation models to screen virtual compounds more effectively”

0/4 platforms mentioned

Core

The High-Stakes Pharma R&D Executive · VP of Early Discovery

ChatGPT

1.ESM

2.ProtBERT

3.AlphaFold2

4.ESMFold

5.ChemBERTa

+25 more

Claude

1.DeepChem

2.BenevolentAI

3.Exscientia

4.Recursion

Gemini

1.NVIDIA BioNeMo

2.MegaMolBART

3.IBM MoL0

4.AlphaFold

5.Recursion

+8 more

AI Overviews

1.ChemBERTa

2.VideoMol

3.LigUnity

4.OpenVS

“ways to simulate human cell response for target ranking, any specific platforms i should check out?”

0/4 platforms mentioned

Core

ChatGPT

1.Open Targets Platform

2.DisGeNET

3.STRING

4.Broad Connectivity Map

5.L1000

+34 more

Claude

1.Emulate

2.Tissue Dynamics

3.Recursion Pharmaceuticals

4.Exscientia

5.Proven

+2 more

Gemini

1.Emulate

2.Human Emulation System

3.CN Bio

4.PhysioMimix

5.Mimetas

+10 more

AI Overviews

1.PandaOmics

2.Insilico Medicine

3.Cell Collective

4.CZI AI Cell Models Platform

5.Chan Zuckerberg Initiative

+5 more

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

De-risking drug discovery with predictive AI | Broad Institute

broadinstitute.org

Web1 ref

The role of machine learning in predictive toxicology: A review of ...

sciencedirect.com

Web1 ref

Can New Approach Methodologies De-Risk Drug ...

criver.com

Web1 ref

AI-based Toxicity Prediction Models using ToxCast Data

sciencedirect.com

Web1 ref

Roadmap to Reducing Animal Testing in Preclinical Safety ...

fda.gov

Gov1 ref

AI in Drug Discovery and Development | Danaher Life Sciences

lifesciences.danaher.com

Web1 ref

Artificial Intelligence (AI) Applications in Drug Discovery and ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Artificial intelligence in drug discovery and development - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Therapeutic Target Identification & Validation with AI | Ardigen

ardigen.com

Web1 ref

How does AI assist in the early detection of drug toxicity?

synapse.patsnap.com

Web1 ref

Artificial intelligence for drug discovery: Resources, methods, ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Artificial intelligence in preclinical research: enhancing digital ...

sciencedirect.com

Web1 ref

AI-driven target discovery: it's a journey - Owkin

owkin.com

Web1 ref

ScienceDirect.com

sciencedirect.com

Web1 ref

MDPI

mdpi.com

Web1 ref

Competitive Landscape

Brands and products that AI platforms mention alongside or instead of CellType.

Schrödinger24 mentions

Exscientia19 mentions

BenevolentAI18 mentions

Insilico Medicine16 mentions

Emulate15 mentions

Atomwise14 mentions

Recursion14 mentions

Insitro14 mentions

AlphaFold11 mentions

MIMETAS9 mentions

CellType8 mentions

Brand Identity

Brand Voice & Style

How AI perceives CellType's communication style and personality

CellType communicates with scientific authority and precision, backed by peer-reviewed research and state-of-the-art benchmarks. The tone is confident yet accessible, translating complex computational biology into clear value propositions for drug development. There's an underlying sense of urgency and ambition—they're solving problems that matter for human health. The voice balances academic credibility (Yale, Nature, Cell publications) with startup energy (Y Combinator backing, bold claims about transforming drug discovery).

Core Tone Traits

Scientifically Authoritative

Leads with peer-reviewed publications, benchmark data, and academic credentials to establish credibility

Confidently Ambitious

Makes bold claims about transforming drug discovery, backed by evidence of real-world validation

Technically Precise

Uses specific metrics, model parameters, and quantitative results rather than vague promises

Urgently Mission-Driven

Conveys that accelerating drug discovery has real human impact and time matters

Backing

Investors

Y Combinator

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned February 27, 2026.